ANGPT1 and type 1 diabetes mellitus: In a rat model of type 1 diabetes, we previously showed that Ang-1-7 is an inhibitor of EGFR tyrosine kinase activity and resultant downstream signaling via ERK1/2 and p38 MAP kinase [5] that might help explain its beneficial actions in the diabetic vasculature.